Federal award
ROCHE DIAGNOSTICS CORPORATION
W81K0019C0005
Contract
Obligated and Ceiling
- Obligated (net)
- $1,193,284.11
- Ceiling (potential value, not spending)
- $1,193,284.11
- Current value
- $1,193,284.11
- Gross positive obligations
- $1,223,284.11
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0019C0005
- Award type code
- D
- Actions
- 8 · Sep 17, 2019 to Oct 21, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 21, 2021 | FY2022 | P00007 | C | $407,761.37 | — |
| Jun 16, 2021 | FY2021 | P00006 | C | −$30,000.00 | — |
| Jun 1, 2021 | FY2021 | P00005 | G | $0.00 | — |
| Dec 21, 2020 | FY2021 | P00004 | C | $407,761.37 | — |
| Sep 24, 2020 | FY2020 | P00003 | B | $0.00 | — |
| Sep 1, 2020 | FY2020 | P00002 | G | $0.00 | — |
| Nov 1, 2019 | FY2020 | P00001 | C | $407,761.37 | — |
| Sep 17, 2019 | FY2019 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.